🇺🇸 FDA
Company

IRONWOOD

IRONWOOD PHARMACEUTICALS INC

IRWD pharma USA

Quick answer

IRONWOOD is a pharma company (IRWD) headquartered in BOSTON, MA, USA with 24 tracked pipeline programs.

Pipeline (24)

project

IW-3718

Gastroesophageal Reflux Disease (GERD)

Phase 3 · small_molecule · terminated

2 trials project

Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 and LIN-MD-64 completers)

Irritable Bowel Syndrome With Constipation

Phase 3 · small_molecule · completed

1 trials project

Linaclotide

Chronic Idiopathic Constipation

Phase 3 · small_molecule · completed

1 trials project

Linaclotide

Functional Constipation

Phase 3 · small_molecule · completed

3 trials project

Linaclotide

Chronic Constipation

Phase 3 · small_molecule · completed

1 trials project

Linaclotide 290 micrograms

Irritable Bowel Syndrome Characterized by Constipation

Phase 3 · small_molecule · completed

1 trials project

Linaclotide 290 micrograms

Chronic Constipation

Phase 3 · small_molecule · completed

2 trials project

Linaclotide or Matching Placebo

Irritable Bowel Syndrome With Constipation

Phase 3 · small_molecule · completed

1 trials project

Matching Placebo

Chronic Constipation

Phase 3 · small_molecule · completed

1 trials project

Placebo

Irritable Bowel Syndrome With Constipation (IBS-C)

Phase 3 · small_molecule · completed

1 trials project

Placebo for Linaclotide

Functional Constipation (FC)

Phase 3 · small_molecule · completed

1 trials project

IW-3300 rectal foam

Interstitial Cystitis

Phase 2 · small_molecule · terminated

1 trials project

IW-3718

Gastroesophageal Reflux Disease

Phase 2 · small_molecule · completed

1 trials project

IW-3718

Gastroesophageal Reflux

Phase 2 · small_molecule · completed

1 trials project

IW-6118

Healthy

Phase 2 · small_molecule · completed

1 trials project

IW-9179

Dyspepsia

Phase 2 · small_molecule · terminated

1 trials project

IW-9179

Diabetic Gastroparesis

Phase 2 · small_molecule · completed

1 trials project

Linaclotide 145 micrograms

Opioid-Induced Constipation

Phase 2 · small_molecule · completed

1 trials project

Linaclotide Acetate

Irritable Bowel Syndrome With Constipation

Phase 2 · small_molecule · completed

1 trials project

Linaclotide Dose A

Irritable Bowel Syndrome With Constipation

Phase 2 · small_molecule · terminated

1 trials project

MD-0727

Hypercholesterolemia

Phase 2 · small_molecule · completed

1 trials project

MD-1100 Acetate

Constipation

Phase 2 · small_molecule · completed

1 trials project

MD-1100 Acetate

Irritable Bowel Syndrome

Phase 2 · small_molecule · completed

1 trials project

MD-7246

Irritable Bowel Syndrome With Diarrhea (IBS-D)

Phase 2 · small_molecule · completed

1 trials

Drugs (2)

drug

allopurinol

ALLOPURINOL

 drug

lesinurad

ZURAMPIC

Patents (8)

patent

US 10702576

Stable formulations of linaclotide

Expires Mon Jul 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10675325

Stable formulations of linaclotide

Expires Mon Jun 04 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10618938

Compositions for colon cleansing and the treatment of gastrointestinal disorders

Expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10266529

Salts, co-crystals, and polymorphs of an anxiolytic compound

Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10189809

SGC stimulators

Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10183021

sGC stimulators

Expires Mon Jan 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 10047095

sGC stimulators

Expires Mon Aug 09 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 9969742

Imidazotriazinone compounds

Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)